These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 51599)

  • 41. Toluene diisocyanate-induced conformational changes of serum albumin: a study on repeated inhalations in guinea-pigs.
    Kochman S; Lefebvre S; Bernard J; Maujean A; Cazabat A; Lavaud F; Manfait M
    Toxicol Lett; 1990 Feb; 50(2-3):165-71. PubMed ID: 2155482
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chronic pulmonary function loss from exposure to toluene diisocyanate.
    Wegman DH; Peters JM; Pagnotto L; Fine LJ
    Br J Ind Med; 1977 Aug; 34(3):196-200. PubMed ID: 199229
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Toluene diisocyanate.
    Peters JM; Wegman DH
    Lancet; 1978 Aug; 2(8087):472. PubMed ID: 79829
    [No Abstract]   [Full Text] [Related]  

  • 44. Five-year longitudinal study of workers employed in a new toluene diisocyanate manufacturing plant.
    Robins J; Greaves IA; Eisen EA
    Am Rev Respir Dis; 1983 Aug; 128(2):327-8. PubMed ID: 6309046
    [No Abstract]   [Full Text] [Related]  

  • 45. A longitudinal study of respiratory health of toluene diisocyanate production workers.
    Bodner KM; Burns CJ; Randolph NM; Salazar EJ
    J Occup Environ Med; 2001 Oct; 43(10):890-7. PubMed ID: 11665458
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detection of urinary amine metabolites in toluene diisocyanate exposed rats.
    Rosenberg C; Savolainen H
    J Chromatogr; 1985 Apr; 323(2):429-33. PubMed ID: 2987281
    [No Abstract]   [Full Text] [Related]  

  • 47. Dose-response relationships for chemical sensitization from TDI and DNCB.
    Huang J; Wang XP; Chen BM; Zhou XJ; Matsushita T
    Bull Environ Contam Toxicol; 1993 Nov; 51(5):732-9. PubMed ID: 7694697
    [No Abstract]   [Full Text] [Related]  

  • 48. Sensory irritation by toluene diisocyanate in single and repeated exposures.
    Sangha GK; Alarie Y
    Toxicol Appl Pharmacol; 1979 Sep; 50(3):533-47. PubMed ID: 229585
    [No Abstract]   [Full Text] [Related]  

  • 49. Inhibition of cholinesterase activity by isocyanates.
    Brown WE; Green AH; Karol MH; Alarie YC
    Toxicol Appl Pharmacol; 1982 Mar; 63(1):45-52. PubMed ID: 6280343
    [No Abstract]   [Full Text] [Related]  

  • 50. [Observations on workers exposed to 2-4-toluene-diisocyanate (Desmodur T)].
    RUTGERS VH
    Ned Tijdschr Geneeskd; 1962 Aug; 106():1726-9. PubMed ID: 14495477
    [No Abstract]   [Full Text] [Related]  

  • 51. Cholinesterases in human toluendiisocyanate exposure.
    Manno M; Lotti M
    Int Arch Occup Environ Health; 1976 Oct; 38(1):55-60. PubMed ID: 185156
    [No Abstract]   [Full Text] [Related]  

  • 52. Indication of DNA strand breaks in human white blood cells after in vitro exposure to toluene diisocyanate (TDI).
    Marczynski B; Czuppon AB; Marek W; Baur X
    Toxicol Ind Health; 1992; 8(3):157-69. PubMed ID: 1323884
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Carcinogenesis results on seven amines, two phenols, and one diisocyanate used in plastics and synthetic elastomers.
    Huff JE
    Prog Clin Biol Res; 1984; 141():347-63. PubMed ID: 6326159
    [No Abstract]   [Full Text] [Related]  

  • 54. Toxicity of chronic low level exposures to toluene diisocyanate in animals.
    Niewenhuis R; Scheel L; Stemmer K; Killens R
    Am Ind Hyg Assoc J; 1965; 26(2):143-9. PubMed ID: 5828116
    [No Abstract]   [Full Text] [Related]  

  • 55. Massachusetts experience with toluene di-isocyanate.
    ELKINS HB; McCARL GW; BRUGSCH HG; FAHY JP
    Am Ind Hyg Assoc J; 1962; 23():265-72. PubMed ID: 13889881
    [No Abstract]   [Full Text] [Related]  

  • 56. Mechanisms of immunotoxicity to isocyanates.
    Karol MH; Jin RZ
    Chem Res Toxicol; 1991; 4(5):503-9. PubMed ID: 1665351
    [No Abstract]   [Full Text] [Related]  

  • 57. Alteration of lung pathology from diisocyanate by glycemic or sensitizing agents.
    Thompson GE; Scheel LD
    Arch Environ Health; 1968 Mar; 16(3):363-70. PubMed ID: 5644741
    [No Abstract]   [Full Text] [Related]  

  • 58. [On the toxicology of toluene diisocyanate].
    HENSCHLER D; ASSMANN W; MEYER KO
    Arch Toxikol; 1962; 19():364-87. PubMed ID: 13953835
    [No Abstract]   [Full Text] [Related]  

  • 59. Development of a compliant surgical adhesive derived from novel fluorinated hexamethylene diisocyanate.
    Matsuda T; Nakajima N; Itoh T; Takakura T
    ASAIO Trans; 1989; 35(3):381-3. PubMed ID: 2557069
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Re: Dieter, M.P., Boorman, G.A., Jameson, C.W., Matthews, H.B., and Huff, J.E. (1990). "The carcinogenic activity of commercial grade toluene diisocyanate in rats and mice in relation to the metabolism of the 2,4- and 2,6-TDI isomers." Toxicol. Ind. Health 6: 599-621.
    Doe JE
    Toxicol Ind Health; 1991 Jul; 7(4):327-31. PubMed ID: 1663667
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.